105 related articles for article (PubMed ID: 1506869)
21. Endothelin-1-like immunoreactivity in cerebral cortex of Alzheimer-type dementia.
Minami M; Kimura M; Iwamoto N; Arai H
Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):509-13. PubMed ID: 7624501
[TBL] [Abstract][Full Text] [Related]
22. Quantitative differences in beta/A4 protein subtypes in the parahippocampal gyrus and frontal cortex in Alzheimer's disease.
Armstrong RA
Dementia; 1994; 5(1):1-5. PubMed ID: 8156080
[TBL] [Abstract][Full Text] [Related]
23. Impaired proteasome function in Alzheimer's disease.
Keller JN; Hanni KB; Markesbery WR
J Neurochem; 2000 Jul; 75(1):436-9. PubMed ID: 10854289
[TBL] [Abstract][Full Text] [Related]
24. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
[TBL] [Abstract][Full Text] [Related]
25. beta-Amyloid protein load is relatively uniform throughout neocortex and hippocampus in elderly Alzheimer's disease patients.
Cairns NJ; Chadwick A; Luthert PJ; Lantos PL
Neurosci Lett; 1991 Aug; 129(1):115-8. PubMed ID: 1922960
[TBL] [Abstract][Full Text] [Related]
26. The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease.
Sampson VL; Morrison JH; Vickers JC
Exp Neurol; 1997 May; 145(1):295-302. PubMed ID: 9184132
[TBL] [Abstract][Full Text] [Related]
27. [Similarities between cerebral amyloid plaques in aged lemurian and in human with Alzheimer's disease].
Bons N; Mestre N
C R Seances Soc Biol Fil; 1993; 187(4):516-25. PubMed ID: 8019922
[TBL] [Abstract][Full Text] [Related]
28. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains.
Tseng HC; Zhou Y; Shen Y; Tsai LH
FEBS Lett; 2002 Jul; 523(1-3):58-62. PubMed ID: 12123804
[TBL] [Abstract][Full Text] [Related]
29. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
Bokde AL; Lopez-Bayo P; Meindl T; Pechler S; Born C; Faltraco F; Teipel SJ; Möller HJ; Hampel H
Brain; 2006 May; 129(Pt 5):1113-24. PubMed ID: 16520329
[TBL] [Abstract][Full Text] [Related]
30. Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease.
Kalaria RN; Sromek SM; Grahovac I; Harik SI
Brain Res; 1992 Jul; 585(1-2):87-93. PubMed ID: 1511337
[TBL] [Abstract][Full Text] [Related]
31. Shared neural activity in panic disorder and undifferentiated somatoform disorder compared with healthy controls.
Koh KB; Kang JI; Lee JD; Lee YJ
J Clin Psychiatry; 2010 Dec; 71(12):1576-81. PubMed ID: 20673555
[TBL] [Abstract][Full Text] [Related]
32. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
[TBL] [Abstract][Full Text] [Related]
33. Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry.
Panayi AE; Spyrou NM; Iversen BS; White MA; Part P
J Neurol Sci; 2002 Mar; 195(1):1-10. PubMed ID: 11867068
[TBL] [Abstract][Full Text] [Related]
34. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Tran VT; Chattha G; Bird ED; Martin JB
Science; 1985 Jul; 229(4710):289-91. PubMed ID: 2861661
[TBL] [Abstract][Full Text] [Related]
35. ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain.
Herrmann M; Golombowski S; Kräuchi K; Frey P; Mourton-Gilles C; Hulette C; Rosenberg C; Müller-Spahn F; Hock C
Eur Neurol; 1999; 42(4):205-10. PubMed ID: 10567816
[TBL] [Abstract][Full Text] [Related]
36. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.
Smith JL; Xiong S; Markesbery WR; Lovell MA
Neuroscience; 2006 Jul; 140(3):879-88. PubMed ID: 16580781
[TBL] [Abstract][Full Text] [Related]
37. Heat-shock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease.
Yoo BC; Seidl R; Cairns N; Lubec G
J Neural Transm Suppl; 1999; 57():315-22. PubMed ID: 10666686
[TBL] [Abstract][Full Text] [Related]
38. Neurochemical phenotype of corticocortical connections in the macaque monkey: quantitative analysis of a subset of neurofilament protein-immunoreactive projection neurons in frontal, parietal, temporal, and cingulate cortices.
Hof PR; Nimchinsky EA; Morrison JH
J Comp Neurol; 1995 Nov; 362(1):109-33. PubMed ID: 8576425
[TBL] [Abstract][Full Text] [Related]
39. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.
Lehtovirta M; Soininen H; Laakso MP; Partanen K; Helisalmi S; Mannermaa A; Ryynänen M; Kuikka J; Hartikainen P; Riekkinen PJ
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):644-9. PubMed ID: 8648331
[TBL] [Abstract][Full Text] [Related]
40. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
